New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.
Researchers sought to determine the efficacy of a Mirasol®-based pathogen-reduction strategy for platelets.
Researchers sought to determine the risk of intraventricular hemorrhage and mortality in preterm infants with lower platelet counts.
Researchers sought to determine whether there was a link between abnormal menstrual bleeding and treatment with anticoagulants for VTE.
Researchers sought to determine whether the addition of IPC to thromboprophylaxis for prevention of VTE is based on sound evidence.
Regardless of vaccination status, adults hospitalized for COVID-19 infection are at increased risk for acute thromboembolism
Researchers sought to examine characteristics of and outcomes for patients with venothromboembolism and concomitant fibroids or gynecologic cancers.
Researchers sought to determine whether patients with cancer were aware of their risk of developing cancer-associated venous thromboembolism.
Researchers conducted an analysis of the Gab2-MALT1 pathway to determine whether it impacts the development of thromboinflammation and deep vein thrombosis.
Researchers sought to determine patters related to age and sex in outcomes for patients with CVT.
Researchers explored the use of D-dimer levels to rule out PTE in patients with COVID-19, as well as clinical associations between D-dimer levels and PTE.
Researchers assessed nationwide trends of venous thromboembolism-related hospitalizations among patients with inflammatory bowel disease.
Researchers assessed the 30-day risk for VTE among ambulatory patients with COVID-19 and compared, via propensity-score matching, individuals without COVID-19 infection.
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Researchers sought to determine whether prophylactic tranexamic acid would improve bleeding outcomes in patients treated for hematologic malignancy at risk of thrombocytopenia.
Researched compared standard vs variable thromboprophylaxis strategies on the risk of mortality among patients hospitalized with COVID-19.
Researchers sought to describe contemporary management across international centers and evaluate outcomes among patients with FNAIT.
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
Researchers sought to characterize the incidence and risk factors for thrombotic events in patients with secondary myelofibrosis.
Investigators sought to assess the effectiveness of heparin in patients hospitalized with COVID-19 and hypercoagulation.
Researchers sought to determine whether patients with virologically suppressed HIV were more likely to have impaired markers of fibrinolysis.
Researchers sought to determine whether neutrophil-to-lymphocyte ratio would be predictive of thrombotic events in patients with polycythemia vera.
Investigators sought to determine the safety and efficacy of varying doses of enoxaparin regimens in patients receiving a bariatric procedure.
Researchers sought to determine whether there was a higher risk of developing thrombosis in patients with MPNs and COVID-19.
The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis.
Researchers sought to determine rates of stroke, stroke-related disability, and presence of neuropsychiatric symptoms in patients with hTTP.
Researchers sought to determine the patterns of coagulation times with concentration of dabigatran in adults and children with VTE.
In an observational study, researchers examined certified stroke center care access between historically underserved and general communities.
Researchers sought to determine whether azathioprine should be evaluated as an option for second-line therapy in patients with of immune-related TTP.
Researchers sought to determine whether prespecified outcomes were different in endovascular thrombectomy with alteplase compared with EVT alone in patients hospitalized with acute ischemic stroke.
Researchers sought to determine whether an assay using flow cytometry may help to diagnose patients who have vaccine-induced immune thrombotic thrombocytopenia.
Researchers sought to determine whether prophylaxis with enoxaparin would be effective in outpatients with COVID-19.
Researchers sought to determine whether thromboprophylaxis with enoxaparin would reduce early hospitalizations and deaths among outpatients with symptomatic COVID-19.
Researchers sought to determine whether there was a link between anti-endothelial cell antibodies and thrombosis in patients with polycythemia vera.
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Researchers sought to determine whether avatrombopag with MSCs would improve platelet recovery in patients with prolonged thrombocytopenia after allo-HSCT.
Researchers sought to determine whether the incidence of CAT was different across designated racial groups.
Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.
Researchers sought to determine the factors that contribute to patients developing clots from Long COVID.
Researchers sought to assess whether patients with migraine had a greater risk for PCiS than ACiS and if patients genetically predisposed to migraine showed an increased risk for PCiS or ACiS.
Researchers sought to determine whether the Khorana score would be able to risk-stratify patients according to the 6-month risk of incident VTE.
Researchers sought to determine whether fondaparinux would be a more cost-effective treatment compared with argatroban in patients with suspected HIT.
What is the best current strategy for addressing patients with COVID-19 who are at high risk for thrombosis but are not in the ICU?
Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.
Medulloblastoma survivors had an increased risk of long-term adverse outcomes.
Researchers sought to compare the efficacy of momelotinib with danazol in patients with thrombocytopenic myelofibrosis who were symptomatic and anemic.
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Researchers sought to determine whether catheter-directed thrombolysis would be effective in patients with postpartum iliofemoral deep venous thrombosis.
Researchers are seeking to address the psychological impact of patients who have survived VTE.
Researchers sought to determine whether rilzabrutinib would be effective in treating immune thrombocytopenia.
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.